↓ Skip to main content

Dove Medical Press

Article Metrics

Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?

Overview of attention for article published in Drug Design, Development and Therapy, July 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
42 Mendeley
Title
Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design?
Published in
Drug Design, Development and Therapy, July 2014
DOI 10.2147/dddt.s64907
Authors

Steven Nathan, Christopher King

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Argentina 1 2%
Unknown 40 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 24%
Student > Bachelor 6 14%
Student > Doctoral Student 5 12%
Student > Ph. D. Student 4 10%
Other 3 7%
Other 9 21%
Unknown 5 12%
Readers by discipline Count As %
Medicine and Dentistry 24 57%
Nursing and Health Professions 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Agricultural and Biological Sciences 2 5%
Computer Science 1 2%
Other 4 10%
Unknown 6 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2014.
All research outputs
#3,052,167
of 4,505,285 outputs
Outputs from Drug Design, Development and Therapy
#332
of 566 outputs
Outputs of similar age
#71,744
of 108,875 outputs
Outputs of similar age from Drug Design, Development and Therapy
#22
of 30 outputs
Altmetric has tracked 4,505,285 research outputs across all sources so far. This one is in the 29th percentile – i.e., 29% of other outputs scored the same or lower than it.
So far Altmetric has tracked 566 research outputs from this source. They receive a mean Attention Score of 2.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,875 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.